Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial-Reference-Cited by-同舟云学术

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial

Published:2023-11-01 Issue:9 Volume:208 Page:917-929
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

McNally Paul¹²^ORCID,Lester Karen¹²,Stone Gavin¹²,Elnazir Basil²,Williamson Michael²,Cox Des²,Linnane Barry³,Kirwan Laura⁴,Rea David²,O’Regan Paul⁴,Semple Tom⁵,Saunders Clare⁵,Tiddens Harm A.W.M.⁶,McKone Edward⁷^ORCID,Davies Jane C.⁵⁸,Lewis Colin,Persaud Thara,McQuaid Aisling,Twomey Eilish,Lambe Aideen,Dodd Johnathan,Short Christopher,Downey Damian,Keown Karen,Broderick Benat,Heffernan Caroline,Thornton Carolyn

Affiliation:

1. Department of Pediatrics, RCSI University of Medicine and Health Sciences, Dublin, Ireland;

2. Children’s Health Ireland, Dublin, Ireland;

3. School of Medicine, University of Limerick, Limerick, Ireland;

4. Cystic Fibrosis Registry of Ireland, Dublin, Ireland;

5. Royal Brompton Hospital, London, United Kingdom;

6. Erasmus Medical Centre, Rotterdam, the Netherlands;

7. St. Vincent’s University Hospital, Dublin, Ireland; and

8. National Heart and Lung Institute, Imperial College London, London, United Kingdom

Funder

Cystic Fibrosis Foundation

Cystic Fibrosis Trust